Sarepta Therapeutics SRPT paid Michael Best Strategies $110K for lobbying in Q3 2025 · Health Issues, Medical

Trade details

Type: Lobbying report
Amount: $110,000
Quarter: Q3 2025
Stock: Sarepta Therapeutics SRPT
Client: Sarepta Therapeutics
Reported: 25/10/20

Up 175.0% from last quarter

What else happened in Sarepta Therapeutics around then

Filed or reported within 30 days of the trade day · 25/08/31~25/10/30

Sarepta Therapeutics's other lobbying reports

Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$50K
$50K
Reported 07/20
for Q2
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$90K
$90K
Reported 07/20
for Q2
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$220K
$220K
Reported 07/20
for Q2
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$110K
$110K
Reported 04/20
for Q1
Sarepta Therapeutics
LobbyingSarepta Therapeutics
Lobbying
Sarepta Therapeutics
SRPT
$270K
$270K
Reported 04/20
for Q1